[Advances in Cardiovascular Medicine Through Molecular Imaging]
Authors
Affiliations
We will witness a change of paradigm in cardiovascular imaging, which is empowered by advances in imaging technology, biochemistry, molecular biology and nanotechnology. Instead of simply following the physical distribution of established contrast agents, we now have the opportunity to noninvasively image biological processes such as enzyme activity, interaction with cell surface markers, gene expression and cell migration. These advancements open up new avenues in basic cardiovascular research and will greatly speed up the pace of discovery. Patient management will profit as well: cardiovascular molecular imaging will strengthen personlized and prophylactic medicine through timely and precise diagnostics. In our review we describe selected molecular imaging strategies in atherosclerosis, myocardial ischemia and healing.
Manoel P, Dike I, Anis H, Yassin N, Wojtara M, Uwishema O Health Sci Rep. 2024; 7(11):e70173.
PMID: 39479287 PMC: 11522615. DOI: 10.1002/hsr2.70173.
Cellular Uptake of Plain and SPION-Modified Microbubbles for Potential Use in Molecular Imaging.
Ahmed M, Cerroni B, Razuvaev A, Harmark J, Paradossi G, Caidahl K Cell Mol Bioeng. 2017; 10(6):537-548.
PMID: 29151981 PMC: 5662700. DOI: 10.1007/s12195-017-0504-9.
Gustafsson B, Hedin U, Caidahl K Contrast Media Mol Imaging. 2014; 10(1):37-42.
PMID: 24753457 PMC: 4374708. DOI: 10.1002/cmmi.1598.